Search PDMR transactions

Notifier
Name of person with notification obligation
Peter Zonabend
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Peter Zonabend
Position
Member of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oasmia Pharmaceutical AB
Issuer´s LEI code
5493003TZPR4B7QO9L49
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Oasmia Pharmaceutical AB SE0000722365 Acquisition 100,000 Quantity 3.026236 SEK 16/07/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oasmia Pharmaceutical AB SE0000722365 Acquisition 16/07/2021 NASDAQ STOCKHOLM AB 100,000 (Quantity) 3.026236 SEK
Total: 100,000
<< Back